{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:12:13Z","timestamp":1790266333363,"version":"4.1.0"},"reference-count":118,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T00:00:00Z","timestamp":1754265600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>Pyroptosis is an inflammatory form of programmed cell death, distinct from apoptosis, necroptosis, and ferroptosis, and is primarily mediated by gasdermin proteins and inflammatory caspases. Recent advances highlight the central role of pyroptosis in the pathogenesis and progression of a spectrum of cardiovascular diseases, including myocardial infarction, myocarditis, heart failure, atherosclerosis, hypertension, and cardiac arrhythmias. Activation of inflammasomes and the subsequent cleavage of gasdermins drive cell membrane pore formation, leading to the release of interleukin-1\u03b2 (IL-1\u03b2), interleukin-18 (IL-18), and other pro-inflammatory mediators, amplifying tissue injury and sterile inflammation. Both experimental and clinical evidence reveal that targeting key molecules in the pyroptotic pathway, such as NLRP3 inflammasome, caspase-1, and gasdermin D, can attenuate myocardial injury, inhibit adverse cardiac remodeling, and stabilise atherosclerotic plaques. This review systematically summarises the current understanding of the molecular mechanisms of pyroptosis in cardiovascular pathology, details its disease-specific roles, and discusses translational and therapeutic perspectives. Modulating pyroptosis may provide new opportunities for the diagnosis, risk stratification, and treatment of cardiovascular diseases.<\/jats:p>","DOI":"10.3389\/fcvm.2025.1629016","type":"journal-article","created":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T06:15:53Z","timestamp":1754288153000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Pyroptosis in cardiovascular diseases: roles, mechanisms, and clinical implications"],"prefix":"10.3389","volume":"12","author":[{"given":"Yuqing","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqiang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,8,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-021-00507-5","article-title":"Pyroptosis: mechanisms and diseases","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"B2","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.smim.2023.101781","article-title":"Pyroptosis-induced inflammation and tissue damage","volume":"69","author":"Vasudevan","year":"2023","journal-title":"Semin Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jmb.2017.09.019","article-title":"How inflammasomes inform adaptive immunity","volume":"430","author":"Evavold","year":"2018","journal-title":"J Mol Biol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1016\/j.bbrc.2017.11.156","article-title":"GSDME mediates caspase-3-dependent pyroptosis in gastric cancer","volume":"495","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B6","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","article-title":"Caspases in cell death, inflammation, and pyroptosis","volume":"38","author":"Kesavardhana","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1097\/FJC.0000000000000717","article-title":"NLRP3 inflammasome in acute myocardial infarction","volume":"74","author":"Mauro","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"102182","DOI":"10.1016\/j.arr.2023.102182","article-title":"Pyroptosis: mechanisms and links with diabetic cardiomyopathy","volume":"94","author":"Liu","year":"2024","journal-title":"Ageing Res Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"897815","DOI":"10.3389\/fcvm.2022.897815","article-title":"Pyroptosis: role and mechanisms in cardiovascular disease","volume":"9","author":"Chen","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1161\/CIRCRESAHA.120.318629","article-title":"GSDMD-mediated cardiomyocyte pyroptosis promotes myocardial I\/R injury","volume":"129","author":"Shi","year":"2021","journal-title":"Circ Res"},{"key":"B11","doi-asserted-by":"publisher","first-page":"e151268","DOI":"10.1172\/JCI151268","article-title":"Gasdermin D inhibition confers antineutrophil-mediated cardioprotection in acute myocardial infarction","volume":"132","author":"Jiang","year":"2022","journal-title":"J Clin Invest"},{"key":"B12","doi-asserted-by":"publisher","first-page":"893914","DOI":"10.3389\/fimmu.2022.893914","article-title":"GSDMD contributes to myocardial reperfusion injury by regulating pyroptosis","volume":"13","author":"Ye","year":"2022","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"19420","DOI":"10.1038\/s41598-024-70477-5","article-title":"Inhibition of caspase-1-dependent pyroptosis alleviates myocardial ischemia\/reperfusion injury during cardiopulmonary bypass (CPB) in type 2 diabetic rats","volume":"14","author":"Zhou","year":"2024","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"14524","DOI":"10.1038\/s41598-024-64710-4","article-title":"Neutrophil NLRP3 promotes cardiac injury following acute myocardial infarction through IL-1\u03b2 production, VWF release and NET deposition in the myocardium","volume":"14","author":"Heger","year":"2024","journal-title":"Sci Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.14744\/AnatolJCardiol.2024.4001","article-title":"The role of pyroptosis in coronary heart disease","volume":"28","author":"Qiu","year":"2024","journal-title":"Anatol J Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1186\/s12872-022-02998-8","article-title":"Elevated circulating levels of gasdermin D are related to acute myocardial infarction and pyrogptosis","volume":"22","author":"Weng","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e934255","DOI":"10.12659\/MSM.934255","article-title":"Role of NLRP3 inflammasome in myocardial ischemia-reperfusion injury and ventricular remodeling","volume":"28","author":"Shen","year":"2022","journal-title":"Med Sci Monit"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e12563","DOI":"10.1111\/cpr.12563","article-title":"Role of pyroptosis in cardiovascular disease","volume":"52","author":"Zhaolin","year":"2019","journal-title":"Cell Prolif"},{"key":"B19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nrcardio.2017.161","article-title":"The NLRP3 inflammasome in acute myocardial infarction","volume":"15","author":"Toldo","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"101809","DOI":"10.1016\/j.smim.2023.101809","article-title":"Pyroptosis in cardiovascular diseases: pumping gasdermin on the fire","volume":"69","author":"Yarovinsky","year":"2023","journal-title":"Semin Immunol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1093\/cvr\/cvab202","article-title":"AIM2-driven Inflammasome activation in heart failure","volume":"117","author":"On\u00f3di","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/ehjcvp\/pvab075","article-title":"Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials","volume":"8","author":"Abbate","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1161\/CIRCRESAHA.120.315937","article-title":"Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease","volume":"126","author":"Abbate","year":"2020","journal-title":"Circ Res"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1093\/eurheartj\/ehw247","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"Van Hout","year":"2017","journal-title":"Eur Heart J"},{"key":"B27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/s10557-018-6781-2","article-title":"The caspase 1 inhibitor VX-765 protects the isolated rat heart via the RISK pathway","volume":"32","author":"Do Carmo","year":"2018","journal-title":"Cardiovasc Drugs Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"114061","DOI":"10.1016\/j.yexcr.2024.114061","article-title":"Pyroptosis inhibitors MCC950 and VX-765 mitigate myocardial injury by alleviating oxidative stress, inflammation, and apoptosis in acute myocardial hypoxia","volume":"438","author":"Ye","year":"2024","journal-title":"Exp Cell Res"},{"key":"B29","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41419-021-04143-3","article-title":"Pyroptosis inhibition improves the symptom of acute myocardial infarction","volume":"12","author":"Liu","year":"2021","journal-title":"Cell Death Dis"},{"key":"B30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s00395-018-0692-z","article-title":"Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function","volume":"113","author":"Audia","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"e1006872","DOI":"10.1371\/journal.ppat.1006872","article-title":"Cathepsin B aggravates coxsackievirus B3-induced myocarditis through activating the inflammasome and promoting pyroptosis","volume":"14","author":"Wang","year":"2018","journal-title":"PLoS Pathog"},{"key":"B32","doi-asserted-by":"publisher","first-page":"20077","DOI":"10.1038\/s41598-022-22617-y","article-title":"IL-37 alleviates coxsackievirus B3-induced viral myocarditis via inhibiting NLRP3 inflammasome-mediated pyroptosis","volume":"12","author":"Sun","year":"2022","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","first-page":"e20212117","DOI":"10.1084\/jem.20212117","article-title":"Viral proteases activate the CARD8 inflammasome in the human cardiovascular system","volume":"219","author":"Nadkarni","year":"2022","journal-title":"J Exp Med"},{"key":"B34","doi-asserted-by":"publisher","first-page":"3384","DOI":"10.3760\/cma.j.cn112137-20230901-00357","article-title":"Investigate the role of neutrophil extracellular traps in immune checkpoint inhibitor-associated myocarditis with programmed death protein-1 inhibitors involvement","volume":"103","author":"Chen","year":"2023","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"B35","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1038\/s41467-024-50996-5","article-title":"Gasdermin-E-mediated pyroptosis drives immune checkpoint inhibitor-associated myocarditis via cGAS-STING activation","volume":"15","author":"Sun","year":"2024","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41392-023-01687-y","article-title":"The role of inflammasomes in human diseases and their potential as therapeutic targets","volume":"9","author":"Yao","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1001\/jamaoncol.2024.3065","article-title":"Immune checkpoint inhibitor-induced cardiotoxicity: a systematic review and meta-analysis","volume":"10","author":"Nielsen","year":"2024","journal-title":"JAMA Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s40959-021-00114-x","article-title":"Immune checkpoint inhibitor-induced myocarditis in cancer patients: a case report and review of reported cases","volume":"7","author":"Matzen","year":"2021","journal-title":"Cardio-oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"107","DOI":"10.3390\/biomedicines11010107","article-title":"Immunopathogenesis of immune checkpoint inhibitor induced myocarditis: insights from experimental models and treatment implications","volume":"11","author":"Wong","year":"2023","journal-title":"Biomedicines"},{"key":"B40","doi-asserted-by":"publisher","first-page":"2505","DOI":"10.1161\/HYPERTENSIONAHA.122.20004","article-title":"GSDMD (Gasdermin D) mediates pathological cardiac hypertrophy and generates a feed-forward amplification cascade via mitochondria-STING (stimulator of interferon genes) axis","volume":"79","author":"Han","year":"2022","journal-title":"Hypertension"},{"key":"B41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12964-023-01466-w","article-title":"cGAS-STING, inflammasomes and pyroptosis: an overview of crosstalk mechanism of activation and regulation","volume":"22","author":"Liu","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B42","doi-asserted-by":"publisher","first-page":"851620","DOI":"10.3389\/fimmu.2022.851620","article-title":"Increased interleukin 18-dependent immune responses are associated with myopericarditis after COVID-19 mRNA vaccination","volume":"13","author":"Won","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.tips.2024.06.002","article-title":"PANoptosis: a novel target for cardiovascular diseases","volume":"45","author":"Xiang","year":"2024","journal-title":"Trends Pharmacol Sci"},{"key":"B44","doi-asserted-by":"publisher","first-page":"366","DOI":"10.31083\/j.rcm2510366","article-title":"Regulated cell death pathways in pathological cardiac hypertrophy","volume":"25","author":"Wu","year":"2024","journal-title":"Rev Cardiovasc Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.2147\/JIR.S348464","article-title":"Protective effect of crocin on immune checkpoint inhibitors-related myocarditis through inhibiting NLRP3 mediated pyroptosis in cardiomyocytes via NF-kappaB pathway","volume":"15","author":"Zhang","year":"2022","journal-title":"J Inflamm Res"},{"key":"B46","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.acvd.2023.07.004","article-title":"Rationale and design of the ARAMIS trial: anakinra versus placebo, a double blind randomized controlled trial for the treatment of acute myocarditis","volume":"116","author":"Kerneis","year":"2023","journal-title":"Arch Cardiovasc Dis"},{"key":"B47","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12929-024-01032-7","article-title":"Targeting NLRP3 signaling reduces myocarditis-induced arrhythmogenesis and cardiac remodeling","volume":"31","author":"Chin","year":"2024","journal-title":"J Biomed Sci"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1038\/s41598-018-20958-1","article-title":"Pyroptosis induced by enterovirus 71 and coxsackievirus B3 infection affects viral replication and host response","volume":"8","author":"Wang","year":"2018","journal-title":"Sci Rep"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1016\/j.jacc.2018.02.021","article-title":"Myocardial interstitial fibrosis in heart failure: biological and translational perspectives","volume":"71","author":"Gonz\u00e1lez","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00395-019-0722-5","article-title":"Inflammation and fibrosis in murine models of heart failure","volume":"114","author":"Bacmeister","year":"2019","journal-title":"Basic Res Cardiol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"870924","DOI":"10.3389\/fcvm.2022.870924","article-title":"Cardiac remodeling in heart failure: role of pyroptosis and its therapeutic implications","volume":"9","author":"Chai","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B52","doi-asserted-by":"publisher","first-page":"101523","DOI":"10.1016\/j.redox.2020.101523","article-title":"NLRP3 inflammasome-mediated pyroptosis contributes to the pathogenesis of non-ischemic dilated cardiomyopathy","volume":"34","author":"Zeng","year":"2020","journal-title":"Redox Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/ijms22031064","article-title":"Emerging role of the inflammasome and pyroptosis in hypertension","volume":"22","author":"De Miguel","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41420-021-00434-y","article-title":"NLRP3-mediated Pyroptosis aggravates pressure overload-induced cardiac hypertrophy, fibrosis, and dysfunction in mice: cardioprotective role of irisin","volume":"7","author":"Yue","year":"2021","journal-title":"Cell Death Discov"},{"key":"B55","doi-asserted-by":"publisher","first-page":"e258","DOI":"10.1038\/nutd.2017.1","article-title":"Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse","volume":"7","author":"Carbone","year":"2017","journal-title":"Nutr Diabetes"},{"key":"B56","doi-asserted-by":"publisher","first-page":"791848","DOI":"10.3389\/fphys.2021.791848","article-title":"Pyroptosis and its regulation in diabetic cardiomyopathy","volume":"12","author":"Lu","year":"2022","journal-title":"Front Physiol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"375","DOI":"10.7555\/JBR.36.20220123","article-title":"Pyroptosis is a drug target for prevention of adverse cardiac remodeling: the crosstalk between pyroptosis, apoptosis, and autophagy","volume":"36","author":"Naryzhnaya","year":"2022","journal-title":"J Biomed Res"},{"key":"B58","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/s41419-020-02777-3","article-title":"Pyroptosis and ferroptosis induced by mixed lineage kinase 3 (MLK3) signaling in cardiomyocytes are essential for myocardial fibrosis in response to pressure overload","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"key":"B59","doi-asserted-by":"publisher","first-page":"e014941","DOI":"10.1161\/JAHA.119.0149","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e025266","DOI":"10.1161\/JAHA.122.02526","article-title":"Colchicine ameliorates dilated cardiomyopathy via SIRT2-mediated suppression of NLRP3 inflammasome activation","volume":"11","author":"Sun","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"B61","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/FJC.0000000000000931","article-title":"Phase 1B, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral NLRP3 inhibitor dapansutrile in subjects with NYHA II-III systolic heart failure","volume":"77","author":"Wohlford","year":"2021","journal-title":"J Cardiovasc Pharmacol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.trsl.2023.09.007","article-title":"Inhibition of gasdermin D palmitoylation by disulfiram is crucial for the treatment of myocardial infarction","volume":"264","author":"Zhuang","year":"2024","journal-title":"Transl Res"},{"key":"B63","doi-asserted-by":"publisher","first-page":"H869","DOI":"10.1152\/ajpheart.00231.2024","article-title":"NLRP3 inflammasome-induced pyroptosis and serum ASC specks are increased in patients with cardiogenic shock","volume":"327","author":"Kogel","year":"2024","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1182\/blood.2023021949","article-title":"Gasdermin D drives focal crystalline thrombotic microangiopathy by accelerating immunothrombosis and necroinflammation","volume":"144","author":"Watanabe-Kusunoki","year":"2024","journal-title":"Blood"},{"key":"B65","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/ijms23010340","article-title":"NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis","volume":"23","author":"Burger","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B66","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1161\/ATVBAHA.123.320612","article-title":"Macrophage-derived GSDMD plays an essential role in atherosclerosis and cross talk between macrophages via the mitochondria-STING-IRF3\/NF-\u03baB axis","volume":"44","author":"Fan","year":"2024","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"100337","DOI":"10.1016\/j.labinv.2024.100337","article-title":"Gasdermin D-mediated pyroptosis promotes the development of atherosclerosis","volume":"104","author":"Huang","year":"2024","journal-title":"Lab Invest"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e012219","DOI":"10.1161\/JAHA.119.012219","article-title":"Novel insights into the NLRP 3 inflammasome in atherosclerosis","volume":"8","author":"Jin","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"B70","doi-asserted-by":"publisher","first-page":"19305","DOI":"10.1038\/s41598-021-98437-3","article-title":"The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci Rep"},{"key":"B71","doi-asserted-by":"publisher","first-page":"79","DOI":"10.15698\/cst2022.10.272","article-title":"Pyroptosis in NLRP3 inflammasome-related atherosclerosis","volume":"6","author":"Zeng","year":"2022","journal-title":"Cell Stress"},{"key":"B72","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler, Thromb, Vasc Biol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"111847","DOI":"10.1016\/j.yexcr.2020.111847","article-title":"VX-765 attenuates atherosclerosis in ApoE deficient mice by modulating VSMCs pyroptosis","volume":"389","author":"Li","year":"2020","journal-title":"Exp Cell Res"},{"key":"B74","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1002\/jcp.27509","article-title":"OxLDL induces vascular endothelial cell pyroptosis through miR-125a-5p\/TET2 pathway","volume":"234","author":"Zhaolin","year":"2019","journal-title":"J Cell Physiol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1161\/hc3901.096721","article-title":"Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability","volume":"104","author":"Mallat","year":"2001","journal-title":"Circulation"},{"key":"B77","doi-asserted-by":"publisher","first-page":"925435","DOI":"10.3389\/fcimb.2022.925435","article-title":"Outer membrane vesicles of Porphyromonas gingivalis trigger NLRP3 inflammasome and induce neuroinflammation, tau phosphorylation, and memory dysfunction in mice","volume":"12","author":"Gong","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","article-title":"Essential hypertension","volume":"370","author":"Messerli","year":"2007","journal-title":"Lancet"},{"key":"B79","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0021-9150(00)00674-2","article-title":"Preactivated monocytes from hypertensive patients as a factor for atherosclerosis?","volume":"157","author":"D\u00f6rffel","year":"2001","journal-title":"Atherosclerosis"},{"key":"B80","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1093\/cvr\/cvy252","article-title":"Pharmacological inhibition of the NLRP3 inflammasome reduces blood pressure, renal damage, and dysfunction in salt-sensitive hypertension","volume":"115","author":"Krishnan","year":"2019","journal-title":"Cardiovasc Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.yjmcc.2019.10.008","article-title":"Programmed death-ligand 1 triggers PASMCs pyroptosis and pulmonary vascular fibrosis in pulmonary hypertension","volume":"138","author":"Zhang","year":"2020","journal-title":"J Mol Cell Cardiol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat Immunol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"54290","DOI":"10.18632\/oncotarget.11091","article-title":"NLRP3 inflammasome activation is involved in Ang II-induced kidney damage via mitochondrial dysfunction","volume":"7","author":"Wen","year":"2016","journal-title":"Oncotarget"},{"key":"B84","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1111\/bph.13230","article-title":"Inflammasome activity is essential for one kidney\/deoxycorticosterone acetate\/salt-induced hypertension in mice","volume":"173","author":"Krishnan","year":"2016","journal-title":"Br J Pharmacol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.phrs.2016.12.015","article-title":"Anakinra reduces blood pressure and renal fibrosis in one kidney\/DOCA\/salt-induced hypertension","volume":"116","author":"Ling","year":"2017","journal-title":"Pharmacol Res"},{"key":"B86","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12974-018-1131-7","article-title":"Central blockade of NLRP3 reduces blood pressure via regulating inflammation microenvironment and neurohormonal excitation in salt-induced prehypertensive rats","volume":"15","author":"Wang","year":"2018","journal-title":"J Neuroinflammation"},{"key":"B87","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","article-title":"Target of MCC950 in inhibition of NLRP3 inflammasome activation: a literature review","volume":"43","author":"Wu","year":"2020","journal-title":"Inflammation"},{"key":"B88","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"B89","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.jacc.2022.03.379","article-title":"Inflammasome signaling in atrial fibrillation","volume":"79","author":"Ajoolabady","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1161\/CIRCRESAHA.120.316710","article-title":"Atrial myocyte NLRP3\/CaMKII nexus forms a substrate for postoperative atrial fibrillation","volume":"127","author":"Heijman","year":"2020","journal-title":"Circ Res"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1093\/eurheartj\/ehaf024","article-title":"Atrial cardiomyocyte-restricted cleavage of gasdermin D promotes atrial arrhythmogenesis","volume":"46","author":"Yuan","year":"2025","journal-title":"Eur Heart J"},{"key":"B92","doi-asserted-by":"publisher","first-page":"893729","DOI":"10.3389\/fcell.2022.893729","article-title":"Epicardial adipose tissue-derived IL-1\u03b2 triggers postoperative atrial fibrillation","volume":"10","author":"Cabaro","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"440","DOI":"10.5603\/KP.a2017.0242","article-title":"Baseline and postoperative levels of C-reactive protein and interleukins as inflammatory predictors of atrial fibrillation following cardiac surgery: a systematic review and meta-analysis","volume":"76","author":"Weymann","year":"2018","journal-title":"Kardiol Pol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"101432","DOI":"10.1016\/j.redox.2020.101432","article-title":"Enhanced cardiomyocyte reactive oxygen species signaling promotes ibrutinib-induced atrial fibrillation","volume":"30","author":"Yang","year":"2020","journal-title":"Redox Biol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/cvr\/cvab024","article-title":"NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias","volume":"117","author":"Scott","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e171102","DOI":"10.1172\/jci.insight.171102","article-title":"Macrophage IL-1\u03b2 mediates atrial fibrillation risk in diabetic mice","volume":"9","author":"Zhou","year":"2024","journal-title":"JCI Insight"},{"key":"B97","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1093\/cvr\/cvab114","article-title":"Gut microbiota dysbiosis promotes age-related atrial fibrillation by lipopolysaccharide and glucose-induced activation of NLRP3-inflammasome","volume":"118","author":"Zhang","year":"2022","journal-title":"Cardiovasc Res"},{"key":"B98","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s41374-021-00635-0","article-title":"LncRNA XIST shuttled by adipose tissue-derived mesenchymal stem cell-derived extracellular vesicles suppresses myocardial pyroptosis in atrial fibrillation by disrupting miR-214-3p-mediated Arl2 inhibition","volume":"101","author":"Yan","year":"2021","journal-title":"Lab Invest"},{"key":"B99","doi-asserted-by":"publisher","first-page":"4938287","DOI":"10.1155\/2023\/4938287","article-title":"Oxidative stress and pyroptosis in doxorubicin-induced heart failure and atrial fibrillation","volume":"2023","author":"Ping","year":"2023","journal-title":"Oxid Med Cell Longev"},{"key":"B100","doi-asserted-by":"publisher","first-page":"104087","DOI":"10.1016\/j.ebiom.2022.104087","article-title":"Akkermansia muciniphila prevents cold-related atrial fibrillation in rats by modulation of TMAO induced cardiac pyroptosis","volume":"82","author":"Luo","year":"2022","journal-title":"EBioMedicine"},{"key":"B101","doi-asserted-by":"publisher","first-page":"8593","DOI":"10.1080\/21655979.2022.2053813","article-title":"MCC950 ameliorates ventricular arrhythmia vulnerability induced by heart failure","volume":"13","author":"Jiang","year":"2022","journal-title":"Bioengineered"},{"key":"B102","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.hlc.2023.09.017","article-title":"Dapansutrile ameliorates atrial inflammation and vulnerability to atrial fibrillation in HFpEF rats","volume":"33","author":"Yang","year":"2024","journal-title":"Heart Lung Circ"},{"key":"B103","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.hroo.2021.03.011","article-title":"Inflammation, atrial fibrillation, and the potential role for colchicine therapy","volume":"2","author":"Varghese","year":"2021","journal-title":"Heart Rhythm O2"},{"key":"B104","doi-asserted-by":"publisher","first-page":"1032116","DOI":"10.3389\/fcvm.2022.1032116","article-title":"Colchicine for prevention of post-operative atrial fibrillation: meta-analysis of randomized controlled trials","volume":"9","author":"Ge","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B105","doi-asserted-by":"publisher","first-page":"4939","DOI":"10.1111\/bph.16470","article-title":"Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation","volume":"181","author":"Niskala","year":"2024","journal-title":"Br J Pharmacol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1111\/pace.13485","article-title":"The effect of statins on the recurrence rate of atrial fibrillation after catheter ablation: a meta-analysis","volume":"41","author":"Peng","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1536\/ihj.20-346","article-title":"The effect of renin-angiotensin system inhibitors on the recurrence of atrial fibrillation after catheter ablation","volume":"61","author":"Zhao","year":"2020","journal-title":"Int Heart J"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e008197","DOI":"10.1161\/CIRCEP.119.008197","article-title":"Canakinumab after electrical cardioversion in patients with persistent atrial fibrillation","volume":"13","author":"Krisai","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1016\/j.jacc.2022.03.337","article-title":"The increasing role of rhythm control in patients with atrial fibrillation","volume":"79","author":"Camm","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"115963","DOI":"10.1016\/j.biopha.2023.115963","article-title":"Empagliflozin alleviates the development of autoimmune myocarditis via inhibiting NF-kappaB-dependent cardiomyocyte pyroptosis","volume":"170","author":"Lv","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"B111","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.intimp.2018.12.028","article-title":"Role of pyroptosis in cardiovascular diseases","volume":"67","author":"Jia","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.7150\/ijbs.33568","article-title":"Role of pyroptosis in cardiovascular diseases and its therapeutic implications","volume":"15","author":"Zeng","year":"2019","journal-title":"Int J Biol Sci"},{"key":"B113","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s11658-024-00576-8","article-title":"miR-29b-3p regulates cardiomyocytes pyroptosis in CVB3-induced myocarditis through targeting DNMT3A","volume":"29","author":"Wang","year":"2024","journal-title":"Cell Mol Biol Lett"},{"key":"B114","doi-asserted-by":"publisher","first-page":"104665","DOI":"10.4239\/wjd.v16.i6.104665","article-title":"Ferroptosis: a novel therapeutic target for diabetic cardiomyopathy","volume":"16","author":"Li","year":"2025","journal-title":"World J Diabetes"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05301-3","article-title":"Ferritinophagy in cardiovascular diseases: mechanisms and potential therapy","author":"Wang","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B116","doi-asserted-by":"publisher","first-page":"155193","DOI":"10.1016\/j.phymed.2023.155193","article-title":"Lupeol alleviates autoimmune myocarditis by suppressing macrophage pyroptosis and polarization via PPARalpha\/LACC1\/NF-kappaB signaling pathway","volume":"123","author":"Xiong","year":"2024","journal-title":"Phytomedicine"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1016\/j.jacbts.2023.05.008","article-title":"TAK1 activation by NLRP3 deficiency confers cardioprotection against pressure overload-induced cardiomyocyte pyroptosis and hypertrophy","volume":"8","author":"Li","year":"2023","journal-title":"JACC: Basic Trans Sci"},{"key":"B118","doi-asserted-by":"publisher","first-page":"112096","DOI":"10.1016\/j.intimp.2024.112096","article-title":"CXCL4:nLRP3-mediated pyroptosis product that regulates cardiac fibrosis","volume":"133","author":"Wei","year":"2024","journal-title":"Int Immunopharmacol"}],"updated-by":[{"DOI":"10.3389\/fcvm.2025.1680298","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000}}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1629016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T13:25:19Z","timestamp":1758633919000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2025.1629016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,4]]},"references-count":118,"alternative-id":["10.3389\/fcvm.2025.1629016"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2025.1629016","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,4]]},"article-number":"1629016"}}